Circular dichroism measurements. CD spectra were recorded at 37ºC on a Jasco 715 CD spectropolarimeter using a cuvette with a path length of 0.01 cm, a spectral bandwidth of 0.2 nm, and a time constant of 1 second. To obtain CD spectra, RAD51 samples (25-50 µM depending on variant) were pre-dialyzed into buffer containing 20 mM HEPES (pH 7.5), 1 mM MgCl 2 , and 150 mM NaCl. 1 mM ATP was added to some samples prior to obtaining spectra. Each of the recorded spectra was the average of six scans to increase the signal-tonoise ratio. After normalization of signal for protein concentration and subtracting the blank signal for the cuvette and buffer, observed molar ellipticity (θ d , in millidegrees) was converted to mean residue ellipticity (deg*cm 2 *dmol -1 ). The equation θ mr = θ d *M/(c*l*n) was used, where M is the molecular weight, c is the molar residue concentration of protein, l is the path length of the cuvette in centimeters, n is the total number of amino acid residues.
buffer was as described above, without added ATP.
Partial proteolysis assays. Protein conformational changes in response to nucleotide presence were assayed through partial proteolysis as reported with minor modification (45).
In a total volume of 20 µl, 10 µg of RAD51 wild-type or variant protein was incubated in the buffer containing 20 mM Na-HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1 mM dithiothreitol, 0.1 mM EDTA with 10 mM magnesium acetate and 1 mM ATP, ADP, or ATPγS. Reactions were incubated at 37 °C for 15 min in a Perkin-Elmer thermal cycler with heated lid. Then 6 µl aliquots were added to 6 µl 250 ng/µl trypsin. Reaction mixtures were incubated at 37 °C for another 60 min and reactions were stopped by the addition of 4 µl loading buffer containing 0.2 M Tris-HCl (pH 7.0), 8% SDS, 20% β-mercaptoethanol, 20% sucrose, 2 mg/ml bromophenol blue, and followed by 5 minutes boiling. Proteolytic products were resolved by 20% SDS-PAGE and visualized by staining with GelCode Blue Stain (Thermo Scientific). Gels were wrapped in clear plastic wrap and scanned directly with a Hewlett-Packard scanner.
Yeast two-hybrid assays. Wild-type human RAD51 coding sequence from plasmid pET-HsRad51 was PCR amplified and cloned into plasmid pDONR221 with BP Clonase II as described in the Gateway Cloning Technology Instruction Manual (Life Technologies).
QuikChange site-directed mutagenesis was employed to generate the missense mutations D149N, R150Q, and G151D within the HsRad51/pDONR221 vector according to the manufacturer's instructions (Stratagene). Primers are shown in Table 1 . Gateway Cloning (Life Technologies) was further utilized to shuttle each RAD51 insert into a bait (pDEST32) and a prey (pDEST22) vector. All plasmid inserts were sequenced to confirm they were correct by the Vermont Cancer Center DNA Sequencing Facility. Yeast strain MaV203 was transformed with 1 μg of bait and 1 μg of prey vector by the lithium acetate and PEG method (46), and plated on synthetic complete-leu-trp plates. Transformants were selected and tested for β-galactosidase activity as described in the Proquest Two Hybrid System manual (Life Technologies). Briefly, colonies were streaked onto SC-leu-trp plates, grown overnight, and replica plated onto YPAD plates. After 24 hours at 30ºC, streaks were lifted onto nitrocellulose or nylon filters, immersed in liquid nitrogen, placed on Whatman paper soaked in X-gal solution, incubated overnight at 30º C and photographed. Blue streaks are indicative of interaction between proteins.
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